Cargando…

Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPS(TM)) SARS-CoV-2 Vaccine

Despite the remarkable success of SARS-CoV-2 vaccines, the rise of variants, some of which are more resistant to the effects of vaccination, highlights the potential need for additional COVID-19 vaccines. We used the Multiple Antigen-Presenting System (MAPS) technology, in which proteins are present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cieslewicz, Brian, Makrinos, Daniel, Burke, Heidi, Bree, Dara, Haridas, Renuka, Tonkiss, Ian, Bartsch, Yannic, Alter, Galit, Malley, Richard, Besin, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317729/ https://www.ncbi.nlm.nih.gov/pubmed/35891233 http://dx.doi.org/10.3390/vaccines10071069

Ejemplares similares

Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
por: Bartsch, Yannic C., et al.
Publicado: (2022)

Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration
por: Fregnan, Federica, et al.
Publicado: (2020)

The effect of CELLFOOD(TM) on radiotherapy or combined chemoradiotherapy: preclinical evidence
por: Nuvoli, Barbara, et al.
Publicado: (2019)

Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction
por: Mwape, Innocent, et al.
Publicado: (2017)

Cities by design : the social life of urban form
por: Tonkiss, Fran
Publicado: (2013)

Evolution of functional antibodies following acute Epstein-Barr virus infection
por: Karsten, Christina B., et al.
Publicado: (2022)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix(TM)) Immunogenicity among Infants in Zambia
por: Chauwa, Adriace, et al.
Publicado: (2023)

Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms
por: Bartsch, Yannic, et al.
Publicado: (2021)

Antigenicity, Immunogenicity, Allergenicity
por: Zhang, Jianguo, et al.
Publicado: (2015)

Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
por: Burns, Madeleine D, et al.
Publicado: (2022)

Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens
por: Wylie, Ben, et al.
Publicado: (2019)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023)

Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Burns, Madeleine D., et al.
Publicado: (2023)

AN APPROACH TO THE QUANTITATION OF IMMUNOGENIC ANTIGEN
por: McConahey, Patricia J., et al.
Publicado: (1968)

The Antibodiome—Mapping the Humoral Immune Response to HIV
por: Butler, Audrey L., et al.
Publicado: (2019)

Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018(TM) Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
por: Bajoria, Sakshi, et al.
Publicado: (2023)

Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development
por: Sauna, Zuben E., et al.
Publicado: (2023)

Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis
por: Apicella, Michael A., et al.
Publicado: (2010)

Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli Infections
por: Chorro, Laurent, et al.
Publicado: (2022)

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine( )
por: Maron, Jenny S, et al.
Publicado: (2022)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Immunogenicity of infectious pathogens and vaccine antigens
por: Mahanty, Siddhartha, et al.
Publicado: (2015)

Oxidized Hemoglobin Is Antigenic and Immunogenic in Lupus
por: Jain, Sonia, et al.
Publicado: (2017)

‘2TM proteins’: an antigenically diverse superfamily with variable functions and export pathways
por: Kaur, Jasweer, et al.
Publicado: (2018)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
por: Bartsch, Yannic C., et al.
Publicado: (2021)

BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
por: Bartsch, Yannic C., et al.
Publicado: (2022)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
por: Ou, Li, et al.
Publicado: (2020)

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin–Conditioned Dendritic Cells Induce Regulatory T-Cell Differentiation and Protection of NOD Mice Against Diabetes
por: Besin, Gilles, et al.
Publicado: (2008)

TM-Free and TM-Catalyzed Mechanosynthesis of Functional Polymers
por: Al-Ithawi, Wahab K. A., et al.
Publicado: (2023)

Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05‐09 antigen could be a malaria vaccine candidate
por: Dinga, J. N., et al.
Publicado: (2018)

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
por: Kaplonek, Paulina, et al.
Publicado: (2022)

PERSISTENCE OF IMMUNOGENICITY OF ANTIGEN AFTER UPTAKE BY MACROPHAGES
por: Unanue, Emil R., et al.
Publicado: (1968)

THE IMMUNOGENICITY OF ANTIGEN BOUND TO THE PLASMA MEMBRANE OF MACROPHAGES
por: Unanue, Emil R., et al.
Publicado: (1970)

Enhanced antigen immunogenicity induced by bispecific antibodies
Publicado: (1990)

TGM4: an immunogenic prostate-restricted antigen
por: Lopez-Bujanda, Zoila A, et al.
Publicado: (2021)

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament‐light chain in multiple sclerosis
por: Gauthier, Audrey, et al.
Publicado: (2021)

Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice
por: Fahimi, Hossein, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sp5cr93944k318sgq2c6d0i1jr